Ekocorp

Ekocorp EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Ekocorp (EKOCORP.NL) as of Oct 22, 2026 is -15.67. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -15.50 — a change of 1.13% (lower).

EV/EBITDA

-15.67

YoY

1.13%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Ekocorp is 2020 -15.67 . EV/EBITDA (Enterprise Value to EBITDA) of Ekocorp was 2019 -15.50 . It decreases by 1.13% lower compared to the previous year.

The Ekocorp EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2015
16.51 NGN
Jan 1, 2016
28.09 NGN
Jan 1, 2017
111.60 NGN
Jan 1, 2018
-17.07 NGN
Jan 1, 2019
-15.50 NGN
Jan 1, 2020
-15.67 NGN
The Ekocorp EV/EBITDA history
YEAREV/EBITDAYoY
-15.67+1.13%
-15.50-9.21%
-17.07-115.30%
111.60+297.26%
28.09+70.11%
16.51—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ekocorp Stock analysis

What does Ekocorp do? Ekocorp PLC provides healthcare services through its segments including standalone facilities, capitation models, and strategic business units such as general outpatients, nursing, intensive care, medical, obstetrics and gynaecology, paediatrics, radiology, and surgery. The company offers specialized medical services like dietician, diabetic nurse educator, foot care specialist, and consultant ophthalmologist. Its consultant services encompass general surgery, orthopaedic surgery, grammatology, otorhinolaryngology, audiology, speech therapy, dental surgery, ophthalmology, radiology, physical medicine (Physiotherapy), endoscopy, anaesthesia, obstetrics and gynaecology, radiotherapy, and oncology. Ekocorp also provides immunological screening services including thyroid antibodies, thyroid adrenal anti-nuclear antibodies, and paediatric endocrinology. The firm targets patients seeking specialized medical care and preventive health services. Its services are delivered through its healthcare delivery model focused on standard medical care and anchor services. Ekocorp's strategic business units serve diverse patient needs across various medical specialties. The company's offerings include both outpatient and inpatient care through its structured segments. Ekocorp PLC's revenue streams come from medical service fees charged to patients and healthcare providers. The company generates income through its consultant services, specialized medical care, and immunological screening services. Its business model relies on delivering high-quality healthcare services across multiple specialties to a broad patient base. The firm's segments operate under a unified healthcare delivery framework that supports its service offerings. Ekocorp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ekocorp stock

EV/EBITDA (Enterprise Value to EBITDA) of Ekocorp is -15.67 in 2020.

EV/EBITDA (Enterprise Value to EBITDA) of Ekocorp changed from -15.50 to -15.67, representing a 1.13% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Ekocorp since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Ekocorp with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Ekocorp

All Key Metrics — Ekocorp